| 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of … F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ... European heart journal 41 (1), 111-188, 2020 | 9994 | 2020 |
| The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials Cholesterol Treatment Trialists' Collaboration The Lancet 380 (9841), 581-590, 2012 | 3185* | 2012 |
| 2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of … RA Byrne, X Rossello, JJ Coughlan, E Barbato, C Berry, A Chieffo, ... European Heart Journal: Acute Cardiovascular Care 13 (1), 55-161, 2024 | 2194 | 2024 |
| Efficacy and safety of LDL‐lowering therapy among men and women: meta‐analysis of individual data from 174,000 participants in 27 randomised trials Cholesterol Treatment Trialists' Collaboration The Lancet 385 (9976), 1397-1405, 2015, 2015 | 1468* | 2015 |
| 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European Heart Journal 44 (37), 3627-3639, 2023 | 1216 | 2023 |
| Review of statistical methods for analysing healthcare resources and costs B Mihaylova, A Briggs, A O'Hagan, SG Thompson Health economics 20 (8), 897-916, 2011 | 850 | 2011 |
| Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials J Armitage, C Baigent, E Barnes, DJ Betteridge, L Blackwell, M Blazing, ... The Lancet 393 (10170), 407-415, 2019 | 779 | 2019 |
| The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference MG Shlipak, SL Tummalapalli, LE Boulware, ME Grams, JH Ix, V Jha, ... Kidney international 99 (1), 34-47, 2021 | 429 | 2021 |
| Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial Heart Protection Study Collaborative Group The Lancet 378 (9808), 2013-2020, 2011 | 341 | 2011 |
| Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy A Halliday, R Bulbulia, LH Bonati, J Chester, A Cradduck-Bamford, R Peto, ... The Lancet 398 (10305), 1065-1073, 2021 | 246 | 2021 |
| The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84) ML Alva, A Gray, B Mihaylova, J Leal, RR Holman Diabetic medicine 32 (4), 459-466, 2015 | 244 | 2015 |
| Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials W Herrington, J Emberson, B Mihaylova, L Blackwell, C Reith, R Haynes, ... Lancet Diabetes and Endocrinology 4 (10), 2016 | 226 | 2016 |
| Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials C Reith, C Baigent, L Blackwell, J Emberson, E Spata, K Davies, H Halls, ... The Lancet 400 (10355), 832-845, 2022 | 171 | 2022 |
| Fibroblast growth factor-23 and risks of cardiovascular and noncardiovascular diseases: a meta-analysis A Marthi, K Donovan, R Haynes, DC Wheeler, C Baigent, CM Rooney, ... Journal of the American Society of Nephrology 29 (7), 2015-2027, 2018 | 169 | 2018 |
| Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20 536 individuals Heart Protection Study Collaborative Group The Lancet 365 (9473), 1779-1785, 2005 | 156 | 2005 |
| Body mass index and healthcare costs: a systematic literature review of individual participant data studies S Kent, F Fusco, A Gray, SA Jebb, BJ Cairns, B Mihaylova Obesity Reviews 18 (8), 869-879, 2017 | 148 | 2017 |
| Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials CT Trialists The Lancet Diabetes & Endocrinology 4 (10), 829-839, 2016 | 138* | 2016 |
| The effect of diabetes complications on health‐related quality of life: the importance of longitudinal data to address patient heterogeneity M Alva, A Gray, B Mihaylova, P Clarke Health economics 23 (4), 487-500, 2014 | 134 | 2014 |
| The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review RL Morton, I Schlackow, B Mihaylova, ND Staplin, A Gray, A Cass Nephrology Dialysis Transplantation 31 (1), 46-56, 2016 | 133 | 2016 |
| What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? S Kent, I Schlackow, J Lozano-Kühne, C Reith, J Emberson, R Haynes, ... BMC nephrology 16, 1-8, 2015 | 127 | 2015 |
Dr Karen Gerard BSc, MSc, PhDFaculty of Health Sciences, University of SouthamptonBestätigte E-Mail-Adresse bei soton.ac.uk